Poseida Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Poseida Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q2 2024.
  • Poseida Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending July 30, 2024 was 97.1M shares, a 11.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 97.1M +10.2M +11.7% Jul 30, 2024 10-Q 2024-08-05
Q1 2024 96.5M +9.96M +11.5% Mar 4, 2024 10-K 2024-03-07
Q3 2023 95.6M +9.68M +11.3% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 86.9M +1.14M +1.33% Aug 4, 2023 10-Q 2023-08-08
Q1 2023 86.5M +24M +38.3% Mar 3, 2023 10-K 2023-03-09
Q3 2022 85.9M +23.4M +37.5% Nov 8, 2022 10-Q 2022-11-10
Q2 2022 85.8M +23.4M +37.6% Aug 8, 2022 10-Q 2022-08-11
Q1 2022 62.5M +439K +0.71% Mar 4, 2022 10-K 2022-03-10
Q3 2021 62.5M +686K +1.11% Nov 5, 2021 10-Q 2021-11-09
Q2 2021 62.3M Aug 6, 2021 10-Q 2021-08-12
Q1 2021 62.1M Mar 5, 2021 10-K 2021-03-11
Q3 2020 61.8M Nov 9, 2020 10-Q 2020-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.